Friday 6 November 2026 Export TXG’s income statement to Excel — free account

10x Genomics

TXG Healthcare Medical Devices

10x Genomics' revenue for fiscal 2025 (year ended December 2025) was $642.8 million, up 5.25% from fiscal 2024.

Revenue: +1.12%
EPS: +31.8%
Free cash flow: −4.61%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

59.18 1.12 +1.93%

Follow TXG

Alert me

Market cap: $7.6B
P/E: 0.0×
Fwd P/E: −95.9×
Dividend yield: —
F-score: 6/9
Altman Z: 3.99
Beneish M: −3.23
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26 From the 10-Q filed 6 Nov
Piotroski F-Score Full definition →	+8 more TTM periods Free account	6	6	5	6
ROE Full definition →		(5.78%)	(2.98%)	(9.40%)	(8.27%)
ROA Full definition →		(4.44%)	(2.36%)	(7.47%)	(6.42%)
ROIC Full definition →		(13.97%)	(8.81%)	(20.20%)	(17.20%)
Return on Tangible Assets Full definition →		(5.75%)	(2.92%)	(9.74%)	(8.51%)
Average Days of Receivables Full definition →		46.84	32.08	29.96	0.00
Free Cash Flow per Share Full definition →		1.04	0.95	0.93	0.72
Free Cash Flow Full definition →		130.12	122.18	121.44	93.77
Capital Expenditures Full definition →		(5.93)	(5.64)	(5.65)	(5.93)
Other line items
Cash ROIC Full definition →		9.86%	9.02%	8.82%	6.63%
Accounts Receivable Turnover Full definition →		7.52	11.75	7.27	0.00
Accounts Payable Turnover Full definition →		15.52	14.13	10.09	8.77
Inventory Turnover Full definition →		2.85	3.03	3.04	2.75
Average Days of Payables Full definition →		23.36	32.76	40.85	45.32
Days of Inventory on Hand Full definition →		103.37	100.55	103.88	135.63
Tax Rate Full definition →		0.09	0.18	0.00	0.03
Research and Development Expense of Revenue Full definition →		37.12%	36.20%	36.76%	35.98%
Selling, General and Administrative Expense of Revenue Full definition →		49.18%	45.83%	48.14%	48.13%
Share Based Compensation of Revenue Full definition →		16.97%	15.76%	16.01%	15.61%
Operating CF/Net income Full definition →		(3.12)	(5.64)	(1.69)	(1.49)
Depreciation/Fixed assets Full definition →		0.19	0.21	0.22	0.00
Capex/Depreciation Full definition →		(0.14)	(0.12)	(0.12)	0.00
Revenue per Share Full definition →		5.15	4.98	4.75	4.73
Operating CF per Share Full definition →		1.09	1.00	0.98	0.76
Capex per Share Full definition →		(0.05)	(0.04)	(0.04)	(0.05)
Capex to Sales Full definition →		0.01	0.01	0.01	0.01

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly